Highlights • Overweight patients with metastatic renal cell carcinoma had an overall survival advantage following first-line therapies. • Obesity paradox may exist in the contemporary cancer immunotherapy era for metastatic…
Highlights • Largest single tertiary center RARC series with the longest follow-up in the U.S. • Extravesical disease and lymph node positivity affect OS and RFS long-term. • Infection and…
Highlights • Suture-free PN is a safe and feasible technique for T1a renal masses. • Suture-free PN benefits short-term and long-term SRF and eGFR compared to conventional Suture PN. Abstract…
Highlights • Micropapillary Urothelial Carcinoma (MPUC) is associated with poor oncologic outcomes. • Unknown whether greater fraction of MPUC component is prognostically relevant. • Largest ever pathologic review and quantification…
Highlights • The effect of 5-alpha reductase inhibitors on upper tract urothelial carcinoma has not been explored. • Men taking 5-alpha reductase inhibitors were identified using Merative TM Marketscan®. •…
Highlights • Mean medical care costs in the year following radical cystectomy were similar between bladder cancer patients who received an ileal conduit and those who received a neobladder. •…
Highlights • Biopsy (RTB) is an optional tool during decision making for renal cancer. • The discordance between biopsy and final surgical pathology is minimal. • The optimal RTB should…
Highlights • The microbiome plays critical roles in immune response to cancer. • Broader efforts are needed to better define the gut and urinary microbiomes. • Microbial metabolites can modulate…
Abstract The gut microbiome is interlinked with renal cell carcinoma (RCC) and its response to systemic treatment. Mounting data suggests that certain elements of the gut microbiome may correlate with…
Highlights • Natural products are well-studied for prostate cancer prevention but less for therapy. • Natural products are used to complement conventional therapies in prostate cancer. • Natural products show…
